AndreaVambutasMD

Otolaryngology (ENT) • New Hyde Park, NY

Neurotology

Professor and Chair of Otolaryngolgy, Zucker School of Medicine at Hofstra/Northwell, Senior Vice President and Executive Director for Otolaryngolgy, Northwell Health System, Chair of Otolaryngolgy at Long Island Jewish Medical Center & North Shore University Hospital

Join to view full profile

Dr. Vambutas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vambutas' full profile

Already have an account?

Office
430 Lakeville Road
New Hyde Park, NY 11040
Phone+1 718-470-7550

Fax+1 718-470-4281

Education & Training

Zucker School of Medicine at Hofstra/NorthwellResidency, Otolaryngology - Head and Neck Surgery, 1993 - 1997
Zucker School of Medicine at Hofstra/NorthwellInternship, Otolaryngology - Head and Neck Surgery, 1992 - 1993
Albert Einstein College of MedicineClass of 1992

Certifications & Licensure

NY State Medical License 1995 - 2026
MN State Medical License 1997 - 2001
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

New York Magazine: Top Doctors Castle Connolly, 2014, 2016
Newsday - Top Doctors on Long Island Castle Connolly, 2010-2014
Top Doctors: New York Metro Area Castle Connolly, 2009-2014
Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
Join now to see all

Clinical Trials

A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease Start of enrollment: 2011 Jun 01
Completed
Phase 1, Phase 2
The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease Start of enrollment: 2013 Aug 01
Completed
Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease Start of enrollment: 2019 Jan 03
Recruiting
Phase 2

Publications & Presentations

PubMed

Hearing Science Accelerator: Sudden Sensorineural Hearing Loss-Executive Summary of Research Initiatives.
William H Slattery 3rd, Ali Andalibi, Simon Angeli, Seilesh Babu, Kristina Bolt
Otology & Neurotology. 2024-12-01
Effect of betahistine on pro-inflammatory cytokine expression in autoimmune inner ear disease and Meniere's disease patients.
Ilana Yellin, Shresh Pathak, Andrea Vambutas
Laryngoscope Investigative Otolaryngology. 2024-12-01
6 citations
NaCl exposure results in increased expression and processing of IL-1β in Meniere's disease patients.
Shresh Pathak, Andrea Vambutas
Scientific Reports. 2022-03-23

Press Mentions

American Otological Society: 154th Annual Spring MeetingApril 23rd, 2021
Otonomy Begins Phase 1/2 Trial of OT-413 for Hearing LossSeptember 17th, 2019
Curbside Consults: Experts Weigh in on Complex Rheumatic ConditionsFebruary 15th, 2024

Grant Support

A Phase I Clinical Trial Of Anakinra For Steroid-Resistant AIEDNational Institute On Deafness And Other Communication Disorders2011
A Decoy Receptor As A Novel Biomarker For Autoimmune Inner EAR DiseaseNational Institute On Deafness And Other Communication Disorders2009–2010
Tap-1/E7 Interaction: Role In Respiratory PapillomasNational Institute On Deafness And Other Communication Disorders2003–2004
Tap-1/E7 Interaction: Role In Respiratory PapillomasNational Institute On Deafness And Other Communication Disorders2002
Regulation Of TAP-1 And MHC-I In Respiratory PapillomasNational Institute On Deafness And Other Communication Disorders1999–2001
Regulation Of TAP-1 And MHC-I In Respiratory PapillomasNational Institute On Deafness And Other Communication Disorders1998